Edges in Network
| Network | GSE16446_top500tf - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | MAX |
| Upstream (Parents) |
|---|
| (<<) RCAN1 → MAX |
| (<<) TP53 → MAX |
| (<<) JUND → MAX |
| (<<) CITED2 → MAX |
| (<<) CREB1 → MAX |
| (<<) SP1 → MAX |
| (<<) NFYC → MAX |
| (<<) TAF12 → MAX |
| (<<) NFYB → MAX |
| (<<) ADNP → MAX |
| (<<) TFE3 → MAX |
| (<<) RELA → MAX |
| Downstream (Children) |
|---|
| MAX → PEG3 (>>) |
| MAX → STAT1 (>>) |
| MAX → SIM2 (>>) |
| MAX → ZEB1 (>>) |
| MAX → GTF2H2 (>>) |
| MAX → TGIF1 (>>) |
| MAX → TFCP2 (>>) |
| MAX → BCL6 (>>) |
| MAX → ZNF268 (>>) |
| MAX → ZNF277 (>>) |
| MAX → GTF2I (>>) |
| MAX → MYNN (>>) |
| MAX → HOXD10 (>>) |
| MAX → SP3 (>>) |
| MAX → HOXD4 (>>) |
| MAX → TAF5L (>>) |
| MAX → RFXAP (>>) |
| MAX → ARNTL (>>) |
| MAX → ATF2 (>>) |
| MAX → TAF5 (>>) |
| MAX → CUX1 (>>) |
| MAX → STRN3 (>>) |
| MAX → SALL2 (>>) |
| MAX → NFIC (>>) |
